Prime, Inc and Teva Neuroscience are offering a free CE course on Case-Based Assessments in Therapeutic Management of Multiple Sclerosis thru September 30, 2011.
Objectives:
**Discuss rationale for early therapeutic intervention in multiple sclerosis and its potential impact upon outcomes
**Assess treatment options for multiple sclerosis and their relative outcomes, including clinical, safety, functional and cost outcomes
**Explore barriers to effective immune modulating therapy and rationale for effective therapeutic switching
Physician Continuing Education
PRIME Education, Inc. (PRIME®) designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment